Cell responses to FGFR3 signalling: growth, differentiation and apoptosis (Q24297423)

fibroblast growth factor receptor 3

Europe PubMed Central

title

Cell responses to FGFR3 signalling: growth, differentiation and apoptosis (English)

0 references

main subject

apoptotic process

0 references

1 reference

Experimental Cell Research

GOA release 2020-03-11

2

Margaret A Knowles

0 references

author name string

Corine G M L'Hôte

series ordinal

1

0 references

language of work or name

English

0 references

publication date

1 April 2005

0 references

published in

0 references

volume

304

0 references

page(s)

417-31

0 references

issue

2

0 references

cites work

FGFR activation in skeletal disorders: too much of a good thing

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Identification of a new fibroblast growth factor receptor, FGFR5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

A novel fibroblast growth factor receptor-5 preferentially expressed in the pancreas(1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Human fibroblast growth factor receptor 3 gene (FGFR3): genomic sequence and primer set information for gene analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Differential effects of heparin saccharides on the formation of specific fibroblast growth factor (FGF) and FGF receptor complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Heparan sulphate glycosaminoglycans derived from endothelial cells and smooth muscle cells differentially modulate fibroblast growth factor-2 biological activity through fibroblast growth factor receptor-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Fibroblast growth factor-specific modulation of cellular response by syndecan-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Fibroblast growth factor signaling and basement membrane assembly are connected during epithelial morphogenesis of the embryoid body

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Cell adhesion and signalling by cadherins and Ig-CAMs in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

N-CAM modulates tumour-cell adhesion to matrix by inducing FGF-receptor signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Structural basis for a direct interaction between FGFR1 and NCAM and evidence for a regulatory role of ATP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Interactions between fibroblast growth factors and Notch regulate neuronal differentiation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Notch activation suppresses fibroblast growth factor-dependent cellular transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

A novel form of FGF receptor-3 using an alternative exon in the immunoglobulin domain III

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Identification of fibroblast growth factor 9 (FGF9) as a high affinity, heparin dependent ligand for FGF receptors 3 and 2 but not for FGF receptors 1 and 4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Expression and biological activity of mouse fibroblast growth factor-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Signal transduction pathway of human fibroblast growth factor receptor 3. Identification of a novel 66-kDa phosphoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Insights into the molecular basis for fibroblast growth factor receptor autoinhibition and ligand-binding promiscuity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Different members of the fibroblast growth factor receptor family are specific to distinct cell types in the developing chicken embryo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Fibroblast growth factor receptor-3 is expressed in undifferentiated intestinal epithelial cells during murine crypt morphogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Fgfr3 expression by astrocytes and their precursors: evidence that astrocytes and oligodendrocytes originate in distinct neuroepithelial domains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Exon III splicing switch of fibroblast growth factor (FGF) receptor-2 and -3 can be induced by FGF-1 or FGF-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Fibroblast growth factor receptor 3 is a negative regulator of bone growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Differential activation of cysteine-substitution mutants of fibroblast growth factor receptor 3 is determined by cysteine localization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Molecular, radiologic, and histopathologic correlations in thanatophoric dysplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Profound ligand-independent kinase activation of fibroblast growth factor receptor 3 by the activation loop mutation responsible for a lethal skeletal dysplasia, thanatophoric dysplasia type II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Activating mutations in the extracellular domain of the fibroblast growth factor receptor 2 function by disruption of the disulfide bond in the third immunoglobulin-like domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Stop codon FGFR3 mutations in thanatophoric dwarfism type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

The transmembrane mutation G380R in fibroblast growth factor receptor 3 uncouples ligand-mediated receptor activation from down-regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

FGF receptors ubiquitylation: dependence on tyrosine kinase activity and role in downregulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Defective lysosomal targeting of activated fibroblast growth factor receptor 3 in achondroplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

The thanatophoric dysplasia type II mutation hampers complete maturation of fibroblast growth factor receptor 3 (FGFR3), which activates signal transducer and activator of transcription 1 (STAT1) from the endoplasmic reticulum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

A novel mutation in FGFR-3 disrupts a putative N-glycosylation site and results in hypochondroplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Proline to arginine mutations in FGF receptors 1 and 3 result in Pfeiffer and Muenke craniosynostosis syndromes through enhancement of FGF binding affinity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Endochondral ossification: a delicate balance between growth and mineralisation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Restrained chondrocyte proliferation and maturation with abnormal growth plate vascularization and ossification in human FGFR-3(G380R) transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

A neonatal lethal mutation in FGFR3 uncouples proliferation and differentiation of growth plate chondrocytes in embryos.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Highly activated Fgfr3 with the K644M mutation causes prolonged survival in severe dwarf mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

A Ser(365)-->Cys mutation of fibroblast growth factor receptor 3 in mouse downregulates Ihh/PTHrP signals and causes severe achondroplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Overexpression of FGFR3, Stat1, Stat5 and p21Cip1 correlates with phenotypic severity and defective chondrocyte differentiation in FGFR3-related chondrodysplasias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Fibroblast growth factor receptor 3 mutations promote apoptosis but do not alter chondrocyte proliferation in thanatophoric dysplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

A network of transcriptional and signaling events is activated by FGF to induce chondrocyte growth arrest and differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Expression of FGFR3 with the G380R achondroplasia mutation inhibits proliferation and maturation of CFK2 chondrocytic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Defective bone mineralization and osteopenia in young adult FGFR3-/- mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Parathyroid hormone receptor type 1/Indian hedgehog expression is preserved in the growth plate of human fetuses affected with fibroblast growth factor receptor type 3 activating mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Signalling by fibroblast growth factor receptor 3 and parathyroid hormone-related peptide coordinate cartilage and bone development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

No evidence for fibroblast growth factor receptor 3 (FGFR-3) R248C/S249C mutations in human prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

No evidence of somatic FGFR3 mutation in various types of carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Frequency of fibroblast growth factor receptor 3 mutations in sporadic tumours.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

A molecular study of the t(4;14) in multiple myeloma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

A subset of multiple myeloma harboring the t(4;14)(p16;q32) translocation lacks FGFR3 expression but maintains an IGH/MMSET fusion transcript

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Mutation, SNP, and isoform analysis of fibroblast growth factor receptor 3 (FGFR3) in 150 newly diagnosed multiple myeloma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

The myeloma-associated oncogene fibroblast growth factor receptor 3 is transforming in hematopoietic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Critical roles for immunoglobulin translocations and cyclin D dysregulation in multiple myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Targeting FGFR3 in multiple myeloma: inhibition of t(4;14)-positive cells by SU5402 and PD173074.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

The incidence of thanatophoric dysplasia mutations in FGFR3 gene is higher in low-grade or superficial bladder carcinomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Immunohistochemical demonstration of cyclin D1 in bladder cancers as an inverse indicator of invasiveness but not an independent prognostic factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Significance of cyclin D1 overexpression in transitional cell carcinomas of the urinary bladder and its correlation with histopathologic features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Cyclin D1 overexpression lacks prognostic significance in superficial urinary bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Cyclin D1 expression in papillary superficial bladder cancer: its association with other cell cycle-associated proteins, cell proliferation and clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Inhibition of fibroblast growth factor receptor 3 induces differentiation and apoptosis in t(4;14) myeloma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

A novel alternatively spliced fibroblast growth factor receptor 3 isoform lacking the acid box domain is expressed during chondrogenic differentiation of ATDC5 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

FGFR3 isoforms have distinct functions in the regulation of growth and cell morphology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Fibroblast growth factor receptors (FGFRs) localize in different cellular compartments. A splice variant of FGFR-3 localizes to the nucleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Altered intracellular localization of fibroblast growth factor receptor 3 in human breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Fibroblast growth factor receptor 3 lacking the Ig IIIb and transmembrane domains secreted from human squamous cell carcinoma DJM-1 binds to FGFs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Identification and characterization of soluble isoform of fibroblast growth factor receptor 3 in human SaOS-2 osteosarcoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

FGFR3IIIS: a novel soluble FGFR3 spliced variant that modulates growth is frequently expressed in tumour cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Identification of tyrosine residues in constitutively activated fibroblast growth factor receptor 3 involved in mitogenesis, Stat activation, and phosphatidylinositol 3-kinase activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-gamma 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Fibroblast growth factor receptor 3 induces gene expression primarily through Ras-independent signal transduction pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Enhanced signaling and morphological transformation by a membrane-localized derivative of the fibroblast growth factor receptor 3 kinase domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Fibroblast growth factor inhibits chondrocytic growth through induction of p21 and subsequent inactivation of cyclin E-Cdk2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Identification of the cyclin D1 gene as a target of activating transcription factor 2 in chondrocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

TGFbeta and PTHrP control chondrocyte proliferation by activating cyclin D1 expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

NGF regulates the PC12 cell cycle machinery through specific inhibition of the Cdk kinases and induction of cyclin D1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Concerted overexpression of the genes encoding p21 and cyclin D1 is associated with growth inhibition and differentiation in various carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Activation of the ERK1/2 and p38 mitogen-activated protein kinase pathways mediates fibroblast growth factor-induced growth arrest of chondrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Insulin-like growth factor-1 rescues the mutated FGF receptor 3 (G380R) expressing ATDC5 cells from apoptosis through phosphatidylinositol 3-kinase and MAPK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

p38 MAP kinase signalling is required for hypertrophic chondrocyte differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Deregulated FGFR3 mutants in multiple myeloma cell lines with t(4;14): comparative analysis of Y373C, K650E and the novel G384D mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Interaction of fibroblast growth factor receptor 3 and the adapter protein SH2-B. A role in STAT5 activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

The cytoplasmic tyrosine kinase Pyk2 as a novel effector of fibroblast growth factor receptor 3 activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Phosphorylation of STAT-3 in response to basic fibroblast growth factor occurs through a mechanism involving platelet-activating factor, JAK-2, and Src in human umbilical vein endothelial cells. Evidence for a dual kinase mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

Loss of heterozygosity at 4p16.3 and mutation of FGFR3 in transitional cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.012

10.1016/J.YEXCR.2004.11.012

7 January 2021

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

release_56rfyfo6tnhn7pvogbdbkgkfky

329219

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/56rfyfo6tnhn7pvogbdbkgkfky

mapped directly with Wikidata item

24 November 2022

based on heuristic

329219

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference